Genmab A/S
GMAB$44.67−0.03% 1D
$1,51252-week range$2,635
Updated . Prices are snapshots and may be delayed.
Genmab A/S price chart
+13.02% over 7D
$44.78
$39.35
Oct 27
Oct 28
AI Outlook for Genmab A/S
Bullish posture- Long-term trend+48.1% vs 200-day average
- Medium-term trend+25.1% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Genmab A/S performance
1D
−0.0%
7D
+14.3%
30D
+26.5%
90D
+56.6%
1Y
+56.1%
About Genmab A/S
Genmab A/S is a biotechnology company based in Denmark, listed on OMX NORDIC EXCHANGE COPENHAGEN A/S since 2000 (ticker GMAB).
The shares trade at a price-to-earnings ratio of 28.5.
Genmab A/S market data
What is the price of Genmab A/S today?
Genmab A/S (GMAB) is at $44.67, −0.03% on the day.
What is the 52-week range of Genmab A/S?
Over the past year Genmab A/S has traded between $1,512 and $2,635. It is currently -131% of the way up that range.
What is the P/E ratio of Genmab A/S?
Genmab A/S trades at a price-to-earnings ratio of 28.5.
Similar stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$4.05+6.6%
SNTI
Senti Biosciences Holdings, Inc. Common Stock
$0.1867+6.6%
MRNA
Moderna, Inc.
$207.97+4.6%
ALLO
Allogene Therapeutics, Inc.
$1.23+1.7%
PURR
Hyperliquid Strategies Inc.
$9.85+8.6%
PDSB
PDS Biotechnology Corporation
$1.30+22.1%
IBRX
ImmunityBio, Inc.
$8.63+10.5%
CYPH
Cypherpunk Technologies Inc.
$3.14+10.8%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.